Dasabuvir

From WikiMD.org
Jump to navigation Jump to search

Dasabuvir

Dasabuvir (pronounced: dah-sah-BYOO-vir) is a pharmaceutical drug used in the treatment of Hepatitis C. It is a non-nucleoside polymerase inhibitor that prevents the replication of the Hepatitis C virus by binding to the NS5B protein.

Etymology

The name "Dasabuvir" is derived from the drug's chemical structure. The prefix "Dasa-" is a reference to the drug's ten-membered ring structure, while "-buvir" is a common suffix for antiviral drugs that inhibit the NS5B protein.

Usage

Dasabuvir is used in combination with other antiviral drugs, such as ombitasvir, paritaprevir, and ritonavir, in a treatment regimen known as Viekira Pak. This combination therapy is used to treat chronic Hepatitis C infections in adults.

Side Effects

Common side effects of Dasabuvir include fatigue, headache, nausea, and insomnia. In rare cases, it can cause severe liver problems, especially in patients with pre-existing liver disease.

Related Terms

  • Hepatitis C: A viral infection that causes liver inflammation, sometimes leading to serious liver damage.
  • Polymerase inhibitor: A type of antiviral drug that prevents the replication of viral DNA or RNA.
  • NS5B protein: A protein that is essential for the replication of the Hepatitis C virus.
  • Viekira Pak: A combination therapy used to treat chronic Hepatitis C infections in adults.

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski